3172 results for «428»
3172 results
TAVI in challenging scenarios, diving into real-life cases
12 Sep 2025 – From PCR Rio Valves 2025
Navigate the complexities of challenging TAVI cases through real-life clinical scenarios. This session offers valuable insights into managing complications such as aortic regurgitation, bicuspid valves, valve-in-valve procedures, coronary obstruction, and large annulus with left ventricular outflow tract calcification. Participants will gain practical tips and tricks to...
Problem-solving in challenging TAVI cases
11 Sep 2025 – From PCR Rio Valves 2025
Explore complex and challenging TAVI cases with expert-led discussions covering redo TAVI procedures, horizontal aorta anatomy, rapid pacing protocols, lithotripsy-assisted interventions for severe calcific stenosis, and management of procedural complications including valve dislodgement.
Orthotopic mitral devices coming soon
12 Sep 2025 – From PCR Rio Valves 2025
This session provides a forward-looking perspective on emerging orthotopic mitral valve devices for repair and replacement. Discussions focus on new device technologies soon to be available, patient selection criteria, and the specific developmental challenges encountered. Case presentations, including the TVMR Intrepid system, illustrate clinical applications and...
Management of residual and recurrent mitral regurgitation after TEER
12 Sep 2025 – From PCR Rio Valves 2025
Delve into the complexities of managing residual and recurrent mitral regurgitation following Transcatheter Edge-to-Edge Repair (TEER). This session discusses challenges such as late mitral regurgitation, strategies for handling single leaflet detachment, and anatomical considerations that may preclude TEER feasibility.
Redefining and optimising LAA closure - LIVE Case
11 Sep 2025 – From PCR Rio Valves 2025
Supported by an unrestricted educational grant from Boston Scientific
A 78-year-old woman with atrial fibrillation and obesity (BMI 34.3), normal left ventricular function, CHADS-VASCs 5 and HAS-BLED 4, presented with severe gastrointestinal bleeding.
She underwent implantation of a Watchman FLX™ pro under local anesthesia via two right femoral...
Integrating the newest valve guidelines into daily clinical reality
12 Sep 2025 – From PCR Rio Valves 2025
Integrate the 2025 EACTS valve guidelines into your clinical practice with a focus on valvular heart disease management tailored to Latin American realities. This session reviews the most relevant updates on aortic stenosis management and transcatheter approaches for mitral and tricuspid valves.
Watch the interview with Fabien...
TAVI - Take the first step considering life time management
12 Sep 2025 – From PCR Rio Valves 2025
Understand the critical importance of lifetime management in TAVI, emphasizing how the initial procedure impacts long-term results. This session discusses implantation depth, commissural alignment, and their roles beyond coronary access, illustrated through a low-risk young patient case and current durability data.
Seal the deal: echocardioraphy-guided LAA closure for stroke defense
12 Sep 2025 – From PCR Rio Valves 2025
This session focuses on echocardiography-guided left atrial appendage (LAA) closure as a critical strategy for stroke prevention. Attendees will explore optimal cardiac imaging techniques tailored to evolving clinical needs and seasonal considerations. The session also includes comprehensive instruction on post-procedural echocardiographic assessment and post-processing workflows in...
Valve-in-valve and coronary protection
11 Sep 2025 – From PCR Rio Valves 2025
Explore complex valve-in-valve procedures and coronary protection strategies through a series of challenging case presentations. Topics include management of high-risk valve-in-valve scenarios, strategies for degenerated aortic bioprostheses, innovative transcarotid approaches, fenestration stenting for late coronary obstruction, and analysis of valve embolisation events, providing valuable insights for...
Early outcomes and predictors of success in LATAM TAVI experiences
12 Sep 2025 – From PCR Rio Valves 2025
Explore early outcomes and predictors of success from Latin America's evolving experience with Transcatheter Aortic Valve Implantation (TAVI). This session covers innovative approaches such as transfemoral access intravascular lithotripsy compared to angioplasty, conduction disturbances with self-expandable TAVI devices, and insights from regional centers treating severe aortic...
Novelties on how to manage difficult TAVI situations
11 Sep 2025 – From PCR Rio Valves 2025
Stay at the forefront of TAVI management with this session highlighting novel approaches to difficult clinical scenarios. Topics include predictive scoring for pacemaker implantation, impact of baseline frailty on recovery, comparative imaging for coronary stenosis evaluation, physiology-guided PCI in TAVI patients, and outcomes of extrathoracic non-transfemoral...
RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration
04 Nov 2021
Panos Xaplanteris review the RADIANCE-HTN Study, presented by Ajay Kirtane, an international randomized, sham-controlled clinical trial evaluating the safety and efficacy of renal denervation (RDN) in a population of treatment-resistant hypertensive patients.
Author
